Issue 39, 2014

Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity

Abstract

Phpy bridged homodinuclear Ru–Ru (1) and heterodinuclear Ir–Ru complexes (2) have been developed. Complex 2 induces autophagy towards the cisplatin resistant human breast cancer (MCF7) cell line, whereas 1 is inactive.

Graphical abstract: Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity

Supplementary files

Article information

Article type
Communication
Submitted
07 Apr 2014
Accepted
13 Aug 2014
First published
14 Aug 2014

Dalton Trans., 2014,43, 14546-14549

Author version available

Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity

S. K. Tripathy, U. De, N. Dehury, S. Pal, H. S. Kim and S. Patra, Dalton Trans., 2014, 43, 14546 DOI: 10.1039/C4DT01033G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements